BONUS!!! Download part of ExamDumpsVCE ACNS dumps for free: https://drive.google.com/open?id=1Kl_XTHNkV8IO7dlCnI8oSfBtoiX1StZg
Attending ExamDumpsVCE, you will have best exam dumps for the certification of ACNS exam tests. We offer you the most accurate ACNS exam answers that will be your key to pass the certification exam in your first try. There are the best preparation materials for your ACNS Practice Test in our website to guarantee your success in a short time. Please totally trust the accuracy of questions and answers.
| Section | Objectives |
|---|---|
| Topic 1: Clinical Judgment and Advanced Practice Nursing | - Comprehensive health assessment and differential diagnosis
|
| Topic 2: Professional Role Development | - Advanced practice nursing roles and ethics
|
| Topic 3: Patient and Family Outcomes Management | - Care coordination and chronic disease management
|
| Topic 4: Evidence-Based Practice and Research | - Translation of research into clinical practice
|
| Topic 5: Systems Leadership and Quality Improvement | - Healthcare systems improvement
|
Our ACNS practice questions are undetected treasure for you if this is your first time choosing them. These advantages help you get a thorough look in details. First of all, the price of our ACNS exam braindumps is reasonable and affordable, no matter the office staffs or the students can afford to buy them. Secondly, the quality of our ACNS Study Guide is high. You can just look the pass rate of our ACNS training quiz, it is high as 98% to 100%.
NEW QUESTION # 61
Of the following which is a promotility agent you'd prescribe for your patient's gastrointestinal disorder?
Answer: A
Explanation:
To answer the question about which drug is a promotility agent that could be prescribed for a patient's gastrointestinal disorder, it is essential to understand what each listed medication is typically used for and how they function.
**Metoclopramide:** This is the correct answer to the question. Metoclopramide is a well-known promotility agent used primarily to treat nausea, vomiting, and gastroparesis (delayed gastric emptying). It works by enhancing the motility of the stomach and intestines, which helps speed the movement of food through the gastrointestinal tract. It acts by blocking dopamine receptors and increasing the release of acetylcholine in the gut, which stimulates gastric motility and accelerates gastric emptying. It's often prescribed under the brand name Reglan.
**Senna:** This is not a promotility agent but rather a stimulant laxative. Senna works by irritating the lining of the bowel, which causes a laxative effect. It is primarily used to treat constipation and to clear the bowel before diagnostic tests such as colonoscopy. Senna does not enhance the motility of the upper gastrointestinal tract and thus is not useful as a promotility agent.
**Tegaserod:** This medication is a selective 5-HT4 receptor agonist that was used to treat irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation. It works by mimicking the action of serotonin at the 5-HT4 receptor, enhancing peristaltic reflex and intestinal secretion, which helps increase gastrointestinal motility. However, it is not typically classified as a promotility agent like Metoclopramide, and its use has been limited due to concerns over cardiovascular side effects.
**Alosetron:** This drug is a selective 5-HT3 receptor antagonist used primarily for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women. Alosetron works by blocking serotonin receptors in the gastrointestinal tract, reducing bowel motility, and enhancing absorption. It effectively manages symptoms of IBS but does not promote motility; rather, it slows it down in cases of diarrhea-predominant IBS.
In conclusion, among the options provided, Metoclopramide is the only appropriate promotility agent for treating gastrointestinal disorders that involve delayed gastric emptying or reduced motility. The other listed drugs serve different purposes and act through mechanisms that do not enhance gastrointestinal motility in the way promotility agents like Metoclopramide do.
NEW QUESTION # 62
In terms of atrophic vaginitis, the CNS knows that all of the following are true except:
Answer: C
Explanation:
Atrophic vaginitis, also known as vaginal atrophy, primarily occurs in the genital tracts of menopausal women. This condition is associated with decreased estrogen levels, which is typical during menopause. Estrogen is crucial for maintaining the thickness and elasticity of the vaginal walls. As estrogen levels decline, the vaginal tissues become thinner, less elastic, and more susceptible to inflammation, leading to symptoms of atrophic vaginitis.
Contrary to the incorrect statement that atrophic vaginitis occurs because of an excess in estrogen, the condition actually results from a deficiency of this hormone. During menopause, the ovaries gradually produce less estrogen, leading to changes in the urogenital tract that can cause discomfort. Symptoms commonly associated with atrophic vaginitis include vaginal dryness, itching, burning, and dyspareunia (painful intercourse).
Treatment for atrophic vaginitis often involves the administration of topical estrogens. This approach helps replenish estrogen levels directly in the vaginal area, which can alleviate symptoms by restoring the health and function of the vaginal tissues. Topical estrogens are generally considered safe and effective for treating atrophic vaginitis, especially compared to systemic hormone replacement therapy, which has broader effects on the body.
In summary, the statement that atrophic vaginitis occurs because of an excess in estrogen is incorrect. The condition is actually due to a lack of estrogen, which is a key hormone for maintaining the health of vaginal tissues. Treatment typically involves the use of topical estrogens to mitigate symptoms and improve the quality of life for affected women.
NEW QUESTION # 63
Which of these is a Class IC antidysrhythmic you could prescribe for a patient with severe ventricular dysrhythmias?
Answer: B
Explanation:
When considering the treatment of severe ventricular dysrhythmias with a Class IC antiarrhythmic, Propafenone is the appropriate choice from the options given.
Antiarrhythmic drugs are categorized into classes based on their primary mechanism of action. These classes are crucial for determining which drug to use based on the specific type of arrhythmia presented by the patient. Class IC antiarrhythmics, which include drugs like Propafenone, are known for their potent effects on modifying the cardiac conduction tissues without having a significant impact on the duration of the action potential.
Class IC antiarrhythmics work primarily by blocking the sodium channels in the heart, which slows the rate of rise of the action potential and prolongs the conduction of the electrical impulse within the heart. This makes them particularly effective in treating cases of severe ventricular dysrhythmias, where rapid, uncontrolled heart rates need to be controlled.
The other options listed - Procainamide, Mexiletine, and Amiodarone - belong to different classes of antiarrhythmics. Procainamide is a Class IA antiarrhythmic, which not only blocks sodium channels but also exhibits moderate blockade of potassium channels, affecting both the depolarization and repolarization phases of the cardiac cycle. Mexiletine, classified under Class IB, primarily shortens the action potential duration and is more often used for ventricular arrhythmias following myocardial infarction. Amiodarone falls under Class III, which predominantly blocks potassium channels and is used for a variety of arrhythmias, including both ventricular and atrial dysrhythmias.
Given that the question specifically asks for a Class IC antiarrhythmic for severe ventricular dysrhythmias, Propafenone is the correct answer. It is important for healthcare providers to choose the correct class of medication as per the specific type of arrhythmia and patient's overall cardiac profile to ensure efficacy and minimize potential side effects.
NEW QUESTION # 64
You are educating a patient about self-care when she returns home after CABG. She says she cannot wait to take a long tub bath. Which of the following is an appropriate response?
Answer: C
Explanation:
In the context of postoperative care after Coronary Artery Bypass Grafting (CABG), it is important to ensure that the surgical incisions heal properly to prevent infection and promote optimal recovery. One of the key recommendations for patients returning home after CABG surgery is regarding their bathing habits, particularly concerning the type of baths they can take.
While patients who have undergone CABG are generally encouraged to resume certain normal activities, they need to take specific precautions with bathing. Although showering might be allowed shortly after discharge, tub baths are not recommended immediately. This is primarily because tub bathing involves prolonged immersion in water, which can potentially lead to the soaking of the surgical dressings and the incision sites. Keeping these areas dry is crucial to prevent the risk of infection and ensure the incisions heal properly.
Therefore, it is typically advised that CABG patients avoid tub baths for at least the first week after surgery. This timeframe allows the incisions to begin the healing process adequately before being exposed to the potential risks associated with longer exposure to water. Showering, on the other hand, can be controlled more easily to prevent the surgical sites from getting wet. Patients can use waterproof dressings or other protective methods to cover their incisions while showering.
In instructing a patient who is eager to take a tub bath, it is important to emphasize the reasons behind this restriction. Explain that while it is understandable they may want to relax in a bath, doing so could compromise their healing process. Patients should be made aware of how to keep their dressings dry during permissible activities like showering and be informed when it might be safe to resume other types of baths, based on their individual healing progress and the advice of their healthcare provider.
Ultimately, the goal of these instructions is to ensure that the patient's recovery is as smooth and complication-free as possible. Proper education about postoperative care, including details about bathing restrictions, plays a critical role in achieving this outcome.
NEW QUESTION # 65
The CNS understands that she will be treating patients with Title XIX Medicaid of the Social Security Act. The following are accurate statements regarding Medicaid with the exception of:
Answer: B
Explanation:
The question pertains to understanding the rules and regulations regarding Medicaid, which is covered under Title XIX of the Social Security Act. This federal program is designed to assist with medical costs for people with limited income and resources, and it offers benefits not typically covered by Medicare, such as nursing home care and personal care services.
One of the statements provided in the question is that "Providers are allowed to collect from these patients if Medicaid denies the claim." This statement is incorrect and serves as the correct answer to the question. In the Medicaid program, providers who accept Medicaid patients must agree to accept Medicaid's payment as the full payment for their services. If Medicaid denies the claim, the provider generally cannot bill the patient for the denied charges. This rule is in place to protect low-income patients from incurring medical bills they cannot afford, which they might face if Medicaid denies payment and providers are allowed to charge them directly.
Medicaid operates as a joint federal and state program. The federal government provides part of the funding, while states must match a percentage of that funding. Each state administers its own Medicaid program but must follow federal guidelines. The state's flexibility allows it to determine aspects such as the type, amount, duration, and scope of services, which can vary widely between states.
The intention behind Medicaid rules, including the prohibition against billing patients for covered services when claims are denied, is to ensure that financial barriers do not prevent vulnerable populations-such as low-income individuals, the elderly, disabled, blind, and families with dependent children-from accessing necessary medical care. Providers who participate in Medicaid accept these terms, which includes accepting the Medicaid reimbursement as payment in full, thereby agreeing not to pursue additional payment from the patient for any services that Medicaid is supposed to cover.
In summary, the correct answer to the question, "Providers are allowed to collect from these patients if Medicaid denies the claim," is a misstatement about Medicaid's regulations. Providers are indeed not allowed to bill Medicaid patients directly if Medicaid denies the claim, provided the services are ones that Medicaid is expected to cover and the provider has accepted the terms of Medicaid payments. This is fundamental to ensuring that Medicaid fulfills its role in helping those who are financially disadvantaged to receive necessary healthcare.
NEW QUESTION # 66
......
In order to let you have a general idea about our ACNS study engine, we have prepared the free demo in our website. The contents in our free demo are part of the real materials in our ACNS learning dumps. I strongly believe that you can feel the sincerity and honesty of our company, since we are confident enough to give our customers a chance to test our ACNS Preparation materials for free before making their decision. and you will find out the unique charm of our ACNS actual exam.
ACNS Free Sample: https://www.examdumpsvce.com/ACNS-valid-exam-dumps.html
What's more, part of that ExamDumpsVCE ACNS dumps now are free: https://drive.google.com/open?id=1Kl_XTHNkV8IO7dlCnI8oSfBtoiX1StZg